BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cruz SL, Sánchez-Miranda E, Castillo-Arellano JI, Cervantes-Villagrana RD, Ibarra-Sánchez A, González-Espinosa C. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers. Int Immunopharmacol 2018;64:298-307. [PMID: 30243065 DOI: 10.1016/j.intimp.2018.09.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Cervantes-Villagrana RD, Albores-García D, Cervantes-Villagrana AR, García-Acevez SJ. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther 2020;5:99. [PMID: 32555170 DOI: 10.1038/s41392-020-0205-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
2 Ferrara AL, Piscitelli F, Petraroli A, Parente R, Galdiero MR, Varricchi G, Marone G, Triggiani M, Di Marzo V, Loffredo S. Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis. J Immunol Res 2019;2019:5836476. [PMID: 31355297 DOI: 10.1155/2019/5836476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Petrosino S, Schiano Moriello A, Verde R, Allarà M, Imperatore R, Ligresti A, Mahmoud AM, Peritore AF, Iannotti FA, Di Marzo V. Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity. J Neuroinflammation 2019;16:274. [PMID: 31878942 DOI: 10.1186/s12974-019-1671-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
4 Kim I, Kanayama Y, Nishiwaki H, Sugahara T, Nishi K. Structure–Activity Relationships of Fish Oil Derivatives with Antiallergic Activity in Vitro and in Vivo. J Med Chem 2019;62:9576-92. [DOI: 10.1021/acs.jmedchem.9b00994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Tomczyk M, Tomaszewska-Zaremba D, Bochenek J, Herman A, Herman AP. Anandamide Influences Interleukin-1β Synthesis and IL-1 System Gene Expressions in the Ovine Hypothalamus during Endo-Toxin-Induced Inflammation. Animals (Basel) 2021;11:484. [PMID: 33673103 DOI: 10.3390/ani11020484] [Reference Citation Analysis]
6 Kilinc E, Ankarali S, Torun IE, Dagistan Y. Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine. Eur J Neurosci 2020. [PMID: 32639078 DOI: 10.1111/ejn.14897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Oyagawa CRM, Grimsey NL. Cannabinoid receptor CB1 and CB2 interacting proteins: Techniques, progress and perspectives. Methods Cell Biol 2021;166:83-132. [PMID: 34752341 DOI: 10.1016/bs.mcb.2021.06.011] [Reference Citation Analysis]
8 Stasiulewicz A, Znajdek K, Grudzień M, Pawiński T, Sulkowska AJI. A Guide to Targeting the Endocannabinoid System in Drug Design. Int J Mol Sci 2020;21:E2778. [PMID: 32316328 DOI: 10.3390/ijms21082778] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 15.0] [Reference Citation Analysis]
9 Tóth KF, Ádám D, Bíró T, Oláh A. Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System. Molecules 2019;24:E918. [PMID: 30845666 DOI: 10.3390/molecules24050918] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 20.3] [Reference Citation Analysis]
10 Ahmed I, Rehman SU, Shahmohamadnejad S, Zia MA, Ahmad M, Saeed MM, Akram Z, Iqbal HMN, Liu Q. Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders. Molecules 2021;26:3389. [PMID: 34205169 DOI: 10.3390/molecules26113389] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Segura-villalobos D, Ramírez-moreno IG, Martínez-aguilar M, Ibarra-sánchez A, Muñoz-bello JO, Anaya-rubio I, Padilla A, Macías-silva M, Lizano M, González-espinosa C. Mast Cell–Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth. Cells 2022;11:349. [DOI: 10.3390/cells11030349] [Reference Citation Analysis]
12 Calvillo-Robledo A, Cervantes-Villagrana RD, Morales P, Marichal-Cancino BA. The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling. Life Sci 2022;:120596. [PMID: 35500681 DOI: 10.1016/j.lfs.2022.120596] [Reference Citation Analysis]
13 Braile M, Marcella S, Marone G, Galdiero MR, Varricchi G, Loffredo S. The Interplay between the Immune and the Endocannabinoid Systems in Cancer. Cells 2021;10:1282. [PMID: 34064197 DOI: 10.3390/cells10061282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pereira SR, Hackett B, O'Driscoll DN, Sun MC, Downer EJ. Cannabidiol modulation of oxidative stress and signalling. Neuronal Signal 2021;5:NS20200080. [PMID: 34497718 DOI: 10.1042/NS20200080] [Reference Citation Analysis]
15 Hagemann PM, Nsiah-Dosu S, Hundt JE, Hartmann K, Orinska Z. Modulation of Mast Cell Reactivity by Lipids: The Neglected Side of Allergic Diseases. Front Immunol 2019;10:1174. [PMID: 31191542 DOI: 10.3389/fimmu.2019.01174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Della Pietra A, Giniatullin R, Savinainen JR. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine. Int J Mol Sci 2021;22:1204. [PMID: 33530477 DOI: 10.3390/ijms22031204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]